AI assistant
Sending…
RELMADA THERAPEUTICS, INC. — Director's Dealing 2020
Apr 9, 2020
34465_dirs_2020-04-09_3a53d786-7891-4fc7-8625-28f90bb6e4b1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2020-04-09
Reporting Person: SCHMIDT ERIC THOMAS (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-09 | Common Stock | X | 32500 | $6.00 | Acquired | 87500 | Direct |
| 2020-04-09 | Common Stock | X | 12500 | $9.00 | Acquired | 100000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-09 | Warrants to purchase common stock | $6.00 | X | 32500 | Disposed | 2023-12-03 | Common Stock (32500) | Direct |
| 2020-04-09 | Warrants to purchase common stock | $9.00 | X | 12500 | Disposed | 2024-05-14 | Common Stock (12500) | Direct |
More from RELMADA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
May 28
Share Issue/Capital Change
2026
May 13
Regulatory Filings
2026
May 12
Capital/Financing Update
2026
Apr 9
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 12
Capital/Financing Update
2026
Jan 30
Director's Dealing
2025
Dec 16